IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 522 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

DRUG WATCH

Is tapentadol a potential Trojan horse in the postdextropropoxyphene era in India?

Basu Aniruddha, Mahadevan Jayant, Ithal Dhruva, Selvaraj Sowmya, Chand Prabhat Kumar, Murthy Pratima

Year : 2018| Volume: 50| Issue : 1 | Page no: 44-46

   This article has been cited by
 
1 Intravenous tapentadol use related seizures A Case Report
Monisha Seralathan, Gaurav Kumar Singh, Sudheendra Huddar, Leo Mathew, Arun Kandasamy, Jayant Mahadevan
Asian Journal of Psychiatry. 2021; 66: 102911
[Pubmed]  [Google Scholar] [DOI]
2 Interpol review of controlled substances 20162019
Nicole S. Jones, Jeffrey H. Comparin
Forensic Science International: Synergy. 2020; 2: 608
[Pubmed]  [Google Scholar] [DOI]
3 Tapentadol, the new kid on the block in India: Is it time to worry?
Debasish Basu, Tathagata Mahintamini, Abhishek Ghosh, Fazle Roub, BN Subodh, SK Mattoo, Ajit Avasthi
Indian Journal of Psychiatry. 2020; 62(6): 697
[Pubmed]  [Google Scholar] [DOI]
4 Tapentadol abuse and dependence in India
Diptadhi Mukherjee, Lekhansh Shukla, Priyanka Saha, Jayant Mahadevan, Arun Kandasamy, Prabhat Chand, Vivek Benegal, Pratima Murthy
Asian Journal of Psychiatry. 2020; 49: 101978
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow